Scholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company’s investigational treatment for ...
FDA expands approval of VYVGART and VYVGART Hytrulo to all adults living with generalized myasthenia gravis.
At 59, Frampton experienced the first symptoms of IBM, a degenerative muscle disease, which he publicly revealed in 2019 ...
KATE Garraway cuddles up to her new man Liam Halligan as he kicks off a 300km charity bike ride. The Good Morning Britain ...
A CPT says holding a squat 30 to 60 seconds signals elite leg strength after 50. Here's the test and 5 moves to get there.
Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular ...
With an FDA decision date looming for its Duchenne muscular dystrophy (DMD) treatment deramiocel, Capricor Therapeutics has filed a ...
Givinostat will be made available to eligible patients with Duchenne muscular dystrophy after its manufacturer struck a ...
Entrada said Thursday that Cohort 1 demonstrated an increase of 2.36% in dystrophin over a baseline of 4% and an increase of 2.31% in exon skipping over a baseline of 2.66% in treated participants.
Entrada said Thursday that Cohort 1 demonstrated an increase of 2.36% in dystrophin over a baseline of 4% and an increase of 2.31% in exon skipping over a baseline of 2.66% in treated participants.
Entrada identified lower-than-expected plasma exposure in juvenile DMD patients as the cause of the lackluster data. Exposure ...
Sarepta Therapeutics has put in place several initiatives to help its gene therapy Elevidys return to growth, but recovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results